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In this issue of the Journal, two manuscripts are 
published that discuss two relatively uncommon 
diseases that anesthesiologists are often encountered 
when anesthetizing pediatric patients though these 
patients may be seen during adulthood. Caplan et al 
have introduced a and discussed anesthetic 
management of such patients a 19 month old Babyboy 
with history of Medium-chain acyl-coenzyme A 
dehydrogenase deficiency (MCADD) undergoing 
orchidopexy for undescended testis; the patient had 
been diagnosed during newborn screening assessment 
(1). In another case series, Mottaghi et al have 
discussed 3 patients with Klippel–Feil syndrome, 
spanning 6 to 42 years old patients having underlying 
disorder with complicated airway management (2). 
Both of these articles discuss challenges for 
anesthesiologists that mandate more sophisticated 
view towards cellular and molecular mechanisms of 
diseases affecting perioperative anesthetic 
management. In another article, Talebi et al have done 
a review on the cellular and molecular mechanisms in 
perioperative hepatic protection including a thorough 
evaluation of the mechanisms, drugs and methods of 
protection (3). 
MCADD is known as "the most common 
disorder of mitochondrial fatty acid oxidation" as 
discussed by Wiles et al (4, 5), with involvement of 
many vital organs. In their conclusion for MCADD 
patients, Caplan et al have presented a few suggestions; 
their recommendations are in concordance with similar 
studies including Allen et al (6-8): 
 Anesthetic management with special approach 
to multidisciplinary preoperative planning 
 Avoiding prolonged fasting through a number 
of strategies including preoperative 
administration of dextrose added intravenous 
fluids and scheduling the patients as the first 
case of the list  
 Logic and cautious use of anesthetic drugs 
including volatile anesthetics, neuromuscular 
blocking agents, and propofol 
Klippel-Feil syndrome is known as a rare 
disorder involving mainly the cervical spine with 
abnormalities in fusion of at least 2 vertebrae; recent 
developments in cellular medicine has significantly 
affected our clinical practice in these patients (9-11). 
In their case series, Mottaghi et al have discussed each 
patient with its radiologic studies and finally, have 
concluded that in Klippel–Feil syndrome, the 
following strategies should be used; these 
considerations are discussed with some different 
viewpoints in other studies (2, 12, 13): 
 Adequate assessment of the airway with fully 
prepared airway management arsenal 
 Using awake fiberoptic intubation approach 
and if not feasible, using inhalational 
induction and fiberoptic intubation as an 
alternative 
Talebi et al have discussed the very direct 
effects of cellular and molecular medicine on our daily 
anesthesia practice; with especial focus on risk factors 
for anesthetic drugs and the perioperative period events 
(3). 
These findings once again notify us that cellular 
and molecular mechanisms of diseases directly affect 
our clinical perioperative practice. Based on these 
studies and many other recent studies, adopting 
interdisciplinary approach in anesthesia management 
and perioperative care is a necessity if we want to 
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